Erratum: The Evaluation of Polyneuropathies (Neurology. (2011)76: suppl 2 (S6-S13) DOI: 10.1212/WNL.0b013e31820c3622);The evaluation of polyneuropathies

Neurology

Volumn 76, Issue 7 SUPPL. 2, 2011, Pages 1106-

  Burns, Ted M ^a   Mauermann, Michelle L ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN M; PERIPHERAL MYELIN PROTEIN 22;

ADIE SYNDROME; ARTICLE; BLOOD CELL COUNT; CLINICAL EVALUATION; CONSTIPATION; DEMYELINATING NEUROPATHY; DIABETIC NEUROPATHY; ELECTROMYOGRAM; ERYTHROCYTE SEDIMENTATION RATE; GLUCOSE BLOOD LEVEL; HEALTH CARE FACILITY; HEREDITARY MOTOR SENSORY NEUROPATHY; NERVE BIOPSY; NERVE CONDUCTION; ORTHOSTATIC BLOOD PRESSURE; POLYNEUROPATHY; POLYRADICULONEUROPATHY; PREVALENCE; PRIORITY JOURNAL; SENSORY NEUROPATHY;

EID: 79951669477     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000011675     Document Type: Erratum

References (19)

1. England JD, Asbury AK. Peripheral neuropathy. Lancet 2004;363:2151-2161. (Pubitemid 38844159)
2. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981;10:222-226. (Pubitemid 11014365)
3. Mauermann ML, Burns TM. The evaluation of chronic ax-onal polyneuropathies. Semin Neurol 2007;28:133-151.
4. Barohn RJ. Approach to peripheral neuropathy and neu-ronopathy. Semin Neurol 1998;18:7-18.
5. Willison HJ, Winer JB. Clinical evaluation and investigation of neuropathy. J Neurol Neurosurg Psychiatry 2003; 74(suppl II):ii3-ii8.
6. Hughes RA. Peripheral neuropathy. BMJ 2002;324:466-469. (Pubitemid 34169466)
7. Bromberg MB, Smith AG. Toward an efficient method to evaluate peripheral neuropathies. J Clin Neuromuscul Dis 2002;3:172-182.
8. Koike, H. Iijima M, Sugiura M, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003;54:19-29. (Pubitemid 36764978)
9. Lewis RA. Toxic and deficiency neuropathies. Continuum Lifelong Learning Neurol 2003;9:160-181.
10. Gorson KC, Ropper AH. Additional causes for distal sensory polyneuropathy in diabetic patients. J Neurol Neuro-surg Psychiatry 2006;77:354-358.
11. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002; 26:173-188. (Pubitemid 34832799)
12. England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review): report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiag-nostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72:185-192.
13. England JD, Gronseth GS, Franklin G, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review): report of the American Academy of Neurology, American Association of Neuromuscu-lar and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72:177-184.
14. Sinnreich M, Taylor BV, Dyck PJ. Diabetic neuropathies: classification, clinical features, and pathophysiological basis. Neurologist 2005;11:63-79. (Pubitemid 40388430)
15. Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999;53:2113-2121.
16. Smith AG, Singleton JR. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 2006;242:9-14.
17. Saperstein DS, Wolfe GI, Gronseth GS, et al. Challenges in the identification of cobalamin-deficiency polyneurop-athy. Arch Neurol 2003;60:1296-301.
18. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998;338:1601-1607. (Pubitemid 28243991)
19. Saperstein DS. Chronic acquired demyelinating polyneu-ropathies. Semin Neurol 2008;28:168-184.